Gapping up
In reaction to strong earnings/guidance: ECOM +32%, (announced the acquisition of E-Tale Holdings Limited), MITK +32%, RPRX +24%, MRC +12.9%, ZNGA +9.7%, NKTR +8.8%, KING +8%, TKMR +7.9%, INFI +7.7%, GST +7.3%, IDRA +6.4%, VOLC +5.8%, LGF +5.6%, FICO +5.3%, BEBE +4.5%, TCPI +4.4%, LMOS +3.3%, GPS +3.2%, (reports Oct same store sales -3% vs -2.4% Retail Metrics consensus; issues upside Q3 EPS guidance, net sales below consensus). CTB +3.2%, NVDA +3%, UNXL +2.9%, NOG +2.6%, EBIX +2.4%, SWKS +2.3%, SPPI +2.3%, ZGNX +2.2%, JOBS +2.1%, KNOP +2.1%, UEPS +2%, MT +2%, PSEC +1.7%, TUMI +1.6%, MNST +0.8%, CMRX +0.8%, XOXO +0.7%
M&A news: AVG +13.3% ( buyers are interested in AVG, according to reports), VPCO +11.1% (Vapor Announces Proposed Merger With Vaporin)
Select metals/mining stocks trading higher: CLF +4%, BHP +2.3%, RIO +2%, VALE +2%
Other news: RMTI +25.3% ( FDA Panel voted 8-3 in favor of recommending approval for Triferic for the treatment of iron loss or iron deficiency ), RPRX +20.8% (co reported it held a "constructive" meeting with the FDA regarding a potential Androxal NDA filing), SHLD +17.8% discloses an update to their estimated Q3 results and actions they are taking to improve their liquidity, including a REIT conversion for a number of their properties PVCT +11.1% (announced it has submitted its phase 3 protocol for evaluation of PV-10 for treatment of locally advanced cutaneous melanoma to the FDA; co also reported earnings), APT +10.4% (Announces Substantial Increase in October Orders), LFVN +8.5% (announced a new $7 mln share repurchase program; co also reported earnings),RDY +4.8% (received FDA approval for Valcyte), WBAI +2.3% (comments on sale of shares by one of its Directors), GPRO +2.1% (cont vol pre-mkt), CTAS +1.3% (announced the sale of its Document Storage and Imaging businesses for ~$180 mln), GNW +1.3% (responds to recent ratings actions)
Analyst comments: TCS +3.1% (upgraded to Buy from Underperform at BofA/Merrill)
In reaction to strong earnings/guidance: ECOM +32%, (announced the acquisition of E-Tale Holdings Limited), MITK +32%, RPRX +24%, MRC +12.9%, ZNGA +9.7%, NKTR +8.8%, KING +8%, TKMR +7.9%, INFI +7.7%, GST +7.3%, IDRA +6.4%, VOLC +5.8%, LGF +5.6%, FICO +5.3%, BEBE +4.5%, TCPI +4.4%, LMOS +3.3%, GPS +3.2%, (reports Oct same store sales -3% vs -2.4% Retail Metrics consensus; issues upside Q3 EPS guidance, net sales below consensus). CTB +3.2%, NVDA +3%, UNXL +2.9%, NOG +2.6%, EBIX +2.4%, SWKS +2.3%, SPPI +2.3%, ZGNX +2.2%, JOBS +2.1%, KNOP +2.1%, UEPS +2%, MT +2%, PSEC +1.7%, TUMI +1.6%, MNST +0.8%, CMRX +0.8%, XOXO +0.7%
M&A news: AVG +13.3% ( buyers are interested in AVG, according to reports), VPCO +11.1% (Vapor Announces Proposed Merger With Vaporin)
Select metals/mining stocks trading higher: CLF +4%, BHP +2.3%, RIO +2%, VALE +2%
Other news: RMTI +25.3% ( FDA Panel voted 8-3 in favor of recommending approval for Triferic for the treatment of iron loss or iron deficiency ), RPRX +20.8% (co reported it held a "constructive" meeting with the FDA regarding a potential Androxal NDA filing), SHLD +17.8% discloses an update to their estimated Q3 results and actions they are taking to improve their liquidity, including a REIT conversion for a number of their properties PVCT +11.1% (announced it has submitted its phase 3 protocol for evaluation of PV-10 for treatment of locally advanced cutaneous melanoma to the FDA; co also reported earnings), APT +10.4% (Announces Substantial Increase in October Orders), LFVN +8.5% (announced a new $7 mln share repurchase program; co also reported earnings),RDY +4.8% (received FDA approval for Valcyte), WBAI +2.3% (comments on sale of shares by one of its Directors), GPRO +2.1% (cont vol pre-mkt), CTAS +1.3% (announced the sale of its Document Storage and Imaging businesses for ~$180 mln), GNW +1.3% (responds to recent ratings actions)
Analyst comments: TCS +3.1% (upgraded to Buy from Underperform at BofA/Merrill)